Rasph

EIC Accelerator rezultatai

NAUJAUSIUS REZULTATUS RASITE ČIA

European Innovation Council (EIC) Accelerator programa yra paramos sistema pradedantiesiems ir mažoms bei vidutinėms įmonėms (MVĮ) visoje Europoje, siekiant paskatinti naujoves ir technologijų pažangą. Su savo Naujausi rezultatai paskelbti 2024 m. vasario 28 dEIC Accelerator dar kartą pademonstravo savo įsipareigojimą remti novatoriškus projektus, kurių bendras biudžetas yra 285 mln. EUR. Ši analizė apima dotacijų ir blended financing paskirstymą, sėkmės rodiklius įvairiuose etapuose ir laimėjusių įmonių geografinį pasiskirstymą.

Finansavimo paskirstymas: atidžiau pažvelkite į paskirstymą

Paskutiniame finansavimo cikle EIC Accelerator parėmė 42 įmones, demonstruodama įvairias finansavimo galimybes, pritaikytas įvairiems Europos novatorių poreikiams. Finansavimo rūšys skirstomos taip:

  • Grantas pirmas: 12 įmonių (29%) buvo suteiktos dotacijos kaip pradinis finansavimo žingsnis, pabrėžiant EIC lankstumą remiant ankstyvos stadijos inovacijas.
  • Mišrūs finansai: Finansavimo srityje dominuojančios 26 įmonės (62%) gavo blended finance, sujungusios dotacijas ir nuosavą kapitalą, kad suteiktų tvirtą paramą įmonėms, pasirengusioms plėsti.
  • Tik nuosavybė: Viena įmonė (2%) užsitikrino nuosavo kapitalo finansavimą, pabrėždama EIC vaidmenį perimant akcijų paketą perspektyviose įmonėse.
  • Tik dotacija: 3 įmonės (7%) gavo dotacijas be nuosavo kapitalo komponento, daugiausia dėmesio skiriant projektams, turintiems specifinių poreikių, kuriuos galima patenkinti tiesioginiu finansavimu.

Kelias į sėkmę: sėkmės rodiklių analizė

EIC Accelerator atrankos procesas yra griežtas, skirtas didžiausią potencialų poveikį turintiems projektams nustatyti. Sėkmės rodikliai kiekviename paraiškų teikimo proceso etape yra tokie:

  • 1 žingsnis: apytiksliai 70% pareiškėjų praeina šį pradinį etapą, nors tikslūs skaičiai neatskleidžiami.
  • 2 žingsnis: Tik 22% projektų įgyvendinami, tai rodo vis didėjantį paraiškų tikrinimą.
  • 3 veiksmas: Paskutiniame etape pastebimas tolesnis susiaurėjimas, o sėkmės rodiklis – 17%.
  • Kombinuoti sėkmės rodikliai: Bendras 2 ir 3 žingsnius atlikusių kandidatų sėkmės rodiklis yra tik 3,91 TP17T, o bendras sėkmės rodiklis visuose trijuose etapuose yra maždaug 2,71 TP17T.

Geografinė įvairovė: visos Europos poveikis

Paskutinis finansavimo etapas buvo naudingas įmonėms iš 15 skirtingų šalių, demonstruodamas EIC Accelerator visos Europos pasiekiamumą. Vokietija pirmauja su 7 finansuojamomis įmonėmis, Prancūzija – 6, o Ispanija ir Švedija – po 5. Kitos šalys, kuriose kandidatai buvo sėkmingi, yra Suomija (4), Italija (3), Izraelis (2), Nyderlandai (2). Norvegija (2) ir kelios kitos, turinčios po vieną įmonę, įrodančios EIC įsipareigojimą skatinti inovacijas visame žemyne.

Išvada

Naujausi EIC Accelerator finansavimo rezultatai pabrėžia esminį programos vaidmenį remiant Europos inovacijų ekosistemą. Programa, kurios bendras biudžetas yra 285 mln. EUR, parėmė 42 įmones įvairiuose sektoriuose ir šalyse, pabrėžiant Europos technologinio kraštovaizdžio įvairovę ir potencialą. Kadangi EIC Accelerator ir toliau tobulėja, jo poveikis novatoriškų projektų skatinimui ir MVĮ plėtrai yra neabejotinas, todėl jis yra Europos inovacijų politikos kertinis akmuo.

Kruopštus dėmesys įvairiems finansavimo poreikiams, griežtiems atrankos procesams ir įsipareigojimui geografinei įtraukčiai užtikrinti, EIC Accelerator atveria kelią novatoriškesnei ir atsparesnei Europai. Nekantriai laukiame būsimų finansavimo etapų, todėl 2024 m. vasario mėn. rezultatai liudija apie gyvybingą verslumo dvasią, kuri klesti visame žemyne.

Finansavimo duomenys

Finansavimo tipas

  • Pirmiausia suteikite: 12 įmonių (29%)
  • Mišrus finansavimas: 26 įmonės (62%)
  • Tik nuosavas kapitalas: 1 įmonė (2%)
  • Tik dotacija: 3 įmonės (7%)
  • Iš viso: 42 įmonės

Biudžetas

  • Bendras biudžetas: 285 mln

Pabaigos data ir rezultatai

  • EIC Accelerator 2 žingsnio pabaigos data: lapkričio 8 dth 2023
  • Rezultatų publikavimas: vasario 28 dth 2024

Sėkmės rodikliai

  • 1 žingsnis: (apie 70%, nes rezultatai neskelbti)
  • 2 žingsnis: 22%
  • 3 veiksmas: 17%
  • 2 ir 3 žingsniai kartu: 3.9%
  • 1 ir 2 ir 3 žingsniai kartu: (apie 2,71 TP17T)

Finansuojamos šalys

Tarp finansuojamų įmonių yra 15 skirtingų šalių.

  • Vokietija: 7 įmonės
  • Prancūzija: 6 įmonės
  • Ispanija: 5 įmonės
  • Švedija: 5 įmonės
  • Suomija: 4 įmonės
  • Italija: 3 įmonės
  • Izraelis: 2 įmonės
  • Nyderlandai: 2 įmonės
  • Norvegija: 2 įmonės
  • Belgija: 1 įmonė
  • Bulgarija: 1 įmonė
  • Danija: 1 įmonė
  • Airija: 1 įmonė
  • Portugalija: 1 įmonė
  • Slovakija: 1 įmonė

Visi 42 EIC Accelerator laimėtojai nuo lapkričio 8 dth 2023

CompanyAcronymDescriptionCountryYear
D-CRBN BVD-CRBNPlasma-based point-source CCU technology to recycle CO2 into added value chemicals to decarbonize hard- to-abate industriesBelgium2023
Smart Farm Robotix OODRoboAIweederA fully autonomous solar-powered lightweight weeding robot, using AI for plant recognition, precision contact and contactless weeding methods suited for hard soils, hilly terrains and arid climates.Bulgaria2023
Golden Devices GmbHACTIVATINGAdditive Manufactured Automotive Antenna for Autonomous DrivingGermany2023
UniverCell Holding GmbHC2C-CSACustomized 21700 cylindrical cells for special applicationsGermany2023
FERROELECTRIC MEMORY GMBHFe-NVRAMSolving the scaling challenge of the memory industry: high-speed, low-complexity and low-cost non-volatile ferroelectric memory (Fe-NVRAM) made in EUGermany2023
QUBEDOT GMBHiSMILEiSMILE - integrated scalable microLED enginesGermany2023
Lumoview Building Analytics GmbHLumoGen1Pioneering automated building digitisation with Lumoview for empowered decision-making in energy- efficient building renovationGermany2023
Omegga GmbHOmeggaThe world's first low-cost in-ovo sexing solution to finally end chick cullingGermany2023
O11 biomedical GmbHRESPILIQRESPILIQ - enteral CO2 absorption for the therapy of hypercapnic lung failureGermany2023
HYME STORAGE APSHYSEHYdroxide Salt Energy Storage InnovationDenmark2023
AptaTargets, S.L.ApTOLLApTOLL: An innovative neuroprotectant to reduce brain damage in Acute Ischemic Stroke (AIS)Spain2023
FASTBASE SOLUTIONS SOCIEDAD LIMITADAIOO - Improving IOIOO: a novel assay to predict patient response to immune checkpoint inhibitors, optimising patient stratification to these therapies and tripling solid tumour patient outcomes in immuno-oncology.Spain2023
LUXQUANTA TECHNOLOGIES SLMIQROScalable Quantum Cryptography for Ultra-secure Communications in Metropolitan NetworksSpain2023
PLEXIGRID SOCIEDAD LIMITADAPlexigridPlexigrid: Plexar Operated GridsSpain2023
ALIAS ROBOTICS S.L.RISREVOLUTIONISING INDUSTRIAL ROBOTICS WITH THE NEXT GENERATION ROBOT-SPECIFIC AI-POWERED SECURITY PLATFORMSpain2023
IQM FINLAND OYBIGQECBuilding industrial-grade quantum computers with error correction and mitigation capabilitiesFinland2023
SpinDrive OyMAGMA X100The smallest, most affordable and efficient active magnetic bearings for ultra-high-speed applicationsFinland2023
Basemark OyRocksolid ARMaking Driving Safer with Augmented realityFinland2023
VEXLUM OYSEMIQLEAPNovel Semiconductor Lasers for the Industrial Quantum LeapFinland2023
Look Up SpaceATLAS2Acceleration Towards LEO Automatic Space SafetyFrance2023
Defacto Technologies SASEmpoSoCA Paradigm Change for System-on-Chip Design to Enable Higher Performance with Lower Time-to-Market and CostFrance2023
ION-XHYPERIONThe Most Efficient Space Propulsion Ever Put in SpaceFrance2023
QfluidicsQFLUIDICSThe first non-clogging continuous flow reactor technologyFrance2023
Pertinent eco-solutionsVERANOGroundbreaking biocontrol solutions for a resilient agricultureFrance2023
Womed SASWOMEDWOMED: an innovative intrauterine biodegradable polymer-based drug-delivery platformFrance2023
MBRYONICS LIMITEDStarCom OISLStarCom Optical Inter-Satellite Link.Ireland2023
NECTIN THERAPEUTICSNTX1088First-in-class anti-PVR mAb NTX1088 - a novel oncology drug that unlocks the power of human immune system and revolutionizes cancer careIsrael2023
NovelradNVCDMinimally invasive suturing for vascular bore closure and heart defect repairIsrael2023
BETAGLUE TECHNOLOGIES S.P.A.BAT-90A Novel ‘Radiotherapy from Within’ Platform Technology for the Targeted Treatment of Solid Tumours Called ‘BAT-90’Italy2023
MOI COMPOSITES SRLCFM4IndustryContinuous Fiber Manufacturing for IndustryItaly2023
SILK BIOMATERIALS SRLKLISBioSilk fibroin tissue grafting for peripheral nerve repairItaly2023
FLASC B.V.FLASC HPESA novel Renewable Energy Storage System tailored for Offshore ApplicationsNetherlands2023
SALVIA BIOELECTRONICS BVReLifeA new life for people with severe disabling cluster headache: Neuromodulation therapy using safe, minimally- invasive simultaneous stimulation at the front and back of the headNetherlands2023
DoMore Diagnostics ASHistotype PxPrecision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patientsNorway2023
Ocean Visuals ASOWLHyper-Spectral Laser Induced Fluorescence LiDAR to detect Submerged Oil over Water in real-time on a molecular level.Norway2023
DELOX - INVESTIGACAO, PROCESSOS E EQUIPAMENTOS CIENTIFICOS, LDADeloxAirDelox Air - Continuous air bio-decontamination compatible with human presencePortugal2023
Cellfion ABCNF MembraneDevelopment and manufacturing of forest-based membranes for electrochemical energy devicesSweden2023
Compular ABCOMPULARAdvanced Simulation Software With Patented Method Optimised For Battery DevelopmentSweden2023
Millow ABMEATLOWInnovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analoguesSweden2023
GEDEA BIOTECH ABpHyphBreakthrough dual-action OTC tablet for treatment and prevention of both bacterial and fungal vaginitisSweden2023
QLUCORE ABQIandQDThe first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancerSweden2023
POWERFUL MEDICAL s. r. o.OMI AI ECG ModelOMI AI ECG Model - application for more accurate heart attack diagnosisSlovakia2023

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a 2025 pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
Loading
Loading
← Back to Pages